Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,752 across all filing types
Latest filing 2026-05-09 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Newspaper Advertisement in respect of special window for transfer and dematerialization requests of physical shares
Regulatory Filings Classification · 95% confidence The document is a letter from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding a newspaper advertisement about a special window for transfer and dematerialization of physical shares. It includes details about the special window period, eligibility criteria, and contact information for shareholders. The document is essentially an announcement informing the exchanges and shareholders about this special window and the related newspaper advertisement. It does not contain financial statements, management discussion, or any detailed financial or operational data. It is not a report itself but an announcement related to shareholder services and regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-05-09 English
Copy of Newspaper Publication
Regulatory Filings Classification · 100% confidence The document is a letter from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding a newspaper advertisement about a special window for transfer and dematerialization of physical shares. It includes details about the special window period, eligibility criteria, and contact information for shareholders. There is no financial data, no report content, no earnings or management discussion, no voting results, no board changes, no legal proceedings, no capital changes, and no merger or acquisition information. The document is essentially an announcement or notification related to share transfer procedures and regulatory compliance with SEBI circulars. It is not a report or detailed financial filing but a regulatory announcement to stock exchanges and shareholders. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-05-09 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed declaration of voting results and the scrutinizer's report for a meeting of equity shareholders of Torrent Pharmaceuticals Limited held on April 28, 2026. It includes comprehensive voting data, references to the National Company Law Tribunal (NCLT) convened meeting, and approval of a Scheme of Amalgamation. The content focuses on the official results of shareholder votes and the scrutinizer's certification of those results. There is no financial performance data, management discussion, or earnings information. The document is not a report publication announcement since it contains substantive voting results and the scrutinizer's report itself. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-28 English
Declaration of Voting Results and Scrutinizers Report of NCLT convened Meeting of Equity Shareholders
Regulatory Filings
2026-04-28 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed declaration of voting results and the scrutinizer's report for a meeting of equity shareholders of Torrent Pharmaceuticals Limited held on April 28, 2026. It includes comprehensive voting data, references to the National Company Law Tribunal (NCLT) convened meeting, and approval of a Scheme of Amalgamation. The content focuses on the official results of shareholder votes and the scrutinizer's certification of the voting process. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a proxy solicitation or a management report. The document is clearly the official declaration of voting results and the scrutinizer's report related to a shareholder meeting. Therefore, the appropriate classification is "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length and detail support a high confidence score.
2026-04-28 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the proceedings of a National Company Law Tribunal (NCLT) convened meeting of equity shareholders regarding the approval of a Scheme of Amalgamation. It references voting results and regulatory compliance under SEBI Listing Regulations. The document is short (3124 characters) and primarily announces the outcome of a shareholder meeting related to voting on a merger scheme. It does not contain detailed financial data or the full report of the meeting but rather a summary of the voting results and procedural details. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially communicates the voting outcome of a shareholder meeting.
2026-04-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.